Source: International Congress 2018 – Biomarkers for evaluating asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Maia Santos (Coimbra, Portugal), B. Ramos (Coimbra, Portugal), C. Chaves Loureiro (Coimbra, Portugal). Blood eosinophils fluctuation in asthmatics on Omalizumab-a mirror of disease outcomes improvement?. 1083

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophils in COPD: long term variability and clinical outcomes Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Stability of blood eosinophils over time in patients with asthma Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Blood eosinophilia in patients with COPD, a real life evaluation Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Longitudinal measurements of blood eosinophils in relation to COPD outcomes Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Associations between blood eosinophils and decline in lung function among adults with and without asthma Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017 Year: 2018 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017 Year: 2017 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthma Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Blood eosinophils do not reliably reflect airway eosinophils in asthmatic children Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Ageing and disease duration may explain low sputum eosinophils in untreated moderate asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003 Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021